According to Zhitong Finance App, Dongyang Pharmaceutical (06887) announced that from July 24, 2026 to July 30, 2026, Mr. Zhang Yushuai, the controlling shareholder and non-executive director of the company, purchased a total of 1,451,400 H shares at a total cost of about HK$56 million in the open market. As of the date of this announcement and immediately following the share purchase, Mr. Zhang Yushuai directly and indirectly held a total of 295,423,156 shares, accounting for about 51.42% of the total issued shares (excluding treasury shares).

As Mr. Zhang Yushuai told, he has confidence in the Group's long-term development prospects and intrinsic value, and will continue to increase his holdings in the company according to market conditions.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.